Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center
Advertisement
Articles by Salah-Eddin Al-Batran, MD, Krankenhaus Nordwest-University Cancer Center
Advertisement
Latest Updated Articles
Global Use of Frontline Therapy in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Perioperative Strategies in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Is Frontline IO Therapy Appropriate in Gastric Cancer?Published: June 2nd 2020 | Updated:
Metastatic Gastric Cancer: Identifying Disease ProgressionPublished: June 2nd 2020 | Updated:
Emerging Biomarkers in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100Published: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5